rs1051685
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs1051685(A;A) |
| Make rs1051685(A;G) |
| Make rs1051685(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 2 |
| Position | 216205653 |
| Gene | XRCC5 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1051685 |
| dbSNP (classic) | rs1051685 |
| ClinGen | rs1051685 |
| ebi | rs1051685 |
| HLI | rs1051685 |
| Exac | rs1051685 |
| Gnomad | rs1051685 |
| Varsome | rs1051685 |
| LitVar | rs1051685 |
| Map | rs1051685 |
| PheGenI | rs1051685 |
| Biobank | rs1051685 |
| 1000 genomes | rs1051685 |
| hgdp | rs1051685 |
| ensembl | rs1051685 |
| geneview | rs1051685 |
| scholar | rs1051685 |
| rs1051685 | |
| pharmgkb | rs1051685 |
| gwascentral | rs1051685 |
| openSNP | rs1051685 |
| 23andMe | rs1051685 |
| SNPshot | rs1051685 |
| SNPdbe | rs1051685 |
| MSV3d | rs1051685 |
| GWAS Ctlg | rs1051685 |
| GMAF | 0.1433 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
[PMID 21435719] Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide
[PMID 16465622
] Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
[PMID 17901044] Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma.
[PMID 18579371] Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions.
[PMID 18768505] Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
